Home

  Company Profile News & Events Scientific Programme Licensing AIM Rule 26 Feedback Contact Us
 

 

Why give feedback?

As a company involved in the development of anti-viral drugs and vaccines, we need to communicate with people whose lives are affected by herpes or other viral infections. We are continuing to develop new treatments and vaccines for herpes simplex (1 and 2) as well as against papilloma viruses.

Privacy
We do not share information provided to us with any other organisation, and the information is treated as strictly confidential.
 

Feedback questions
Do you or your partner suffer with recurrent herpes infections?
yes no
If yes what area of the body is affected?
Genital region
Mouth
Hands/fingers
Eyes
Other please specify
How often do you or your partner suffer recurrences?
When you suffer with a recurrence of herpes what symptoms affect you?
Typically, how long does an outbreak last?
Have you found any form of therapy that seems to help you?
Would you like to be informed about any research products that may be available for use as a "named patient"?
yes no
Would you like to be considered as a candidate for clinical trials?
yes no

Do you have any other comments?

 

If you have asked us to communicate with you, what is your chosen method of communication? (We never send un-solicited mailings)

Email    Post    Phone   

 

Please fill out your contact details below
   
First Name
Last Name
Email
Phone
Address 1
Address 2
Town/City
County/Province/State
Postcode/Zip
Country
 
 

 

 

To send a message directly to Henderson Morley plc, please use this form, where you may also optionally register an interest in taking part in clinical trials of new products.

Henderson Morley plc
Metropolitan House
2 Salisbury Road
Moseley
Birmingham B13 8JS
Tel +44 (0) 121 442 4600
Fax +44 (0) 121 442 4611
info@henderson-morley.com

 

For the latest corporate announcements, please see the Investor relations page.

Bishopsgate Communications
2nd Floor
Henry Thomas House
5-11 Worship Street
London EC2A 2BH
Tel 0207 562 3350
Fax 0207 628 0889
investors@henderson-morley.com

 
       

Home | Company Profile  | News & Events  | Scientific Programme | Licensing  | Investor Relations  | Feedback  | Contact Us